Cantor Fitzgerald Reiterates Buy on Senomyx (SNMX); $26 PT
Cantor Fitzgerald reiterates its Buy rating on Senomyx (Nasdaq: SNMX) and has a $26 price target on the stock.
The firm said Senomyx is at an inflection point as the Company announced that its "scientists have discovered the human salt taste receptor, SNMX29, the critical enabling step towards identifying and developing salt enhancers or substitutes." Cantor says this discovery will be substantial for not only Senomyx, but also its partner Campbell Soup Company (NYSE: CPB).
As increasingly more and more companies attempt to expand their packaged foods business toward a "health and wellness" strategy, Cantor believes that many company's will target Senomyx's salt compound.
Senomyx, Inc., a biotechnology company, engages in the discovery and development of flavors, flavor enhancers, and taste modulators for the packaged food and beverage industry primarily in the United States.
Campbell Soup Company, together with its subsidiaries, manufactures and markets branded convenience food products worldwide.
Related Categories
Analyst CommentsStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
